Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)

Author:

Soomro G Mustafa1,Altman Douglas G2,Rajagopal Sundararajan3,Oakley Browne Mark4

Affiliation:

1. St. George's Hospital Medical School; Department of Psychiatry; University of London Cranmer Terrace London UK SW17 0RE

2. Wolfson College Annexe; Centre for Statistics in Medicine; Linton Road Oxford UK OX2 6UD

3. South London and Maudsley NHS Trust; Adamson Centre for Mental Health; St Thomas's Hospital London UK SE1 7EH

4. School of Rural Health ; Department of Rural and Indigenous Health ; Faculty of Medicine, Nursing and Health Sciences Monash University PO Box 973 Moe Victoria Australia 3825

Publisher

Wiley

Subject

Pharmacology (medical)

Reference124 articles.

1. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder;Chouinard;1990

2. Sertraline in the treatment of obsessive-compulsive disorder;Clary;American Family Physician,1999

3. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder;Ackerman;Journal of Clinical Psychopharmacology,1998

4. Side effects as predictors of drug response in obsessive-compulsive disorder;Ackerman;Journal of Clinical Psychopharmacology,1999

5. Serotonergic antidepressants and their efficacy in obsessive compulsive disorder;Dominguez;Journal of Clinical Psychiatry,1992

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3